A diverse picture of cognitive functioning in patients with multiple sclerosis Review article
Article Sidebar
Published:
Sep 30, 2020
Keywords:
cognitive functioning, assessment methods, multiple sclerosis
Main Article Content
Abstract
The authors present methodological difficulties in assessing cognitive functioning in a very diverse group of patients with multiple sclerosis. They cause that the generalization of conclusions from research presented in the literature on the subject has some limitations. The reader has the opportunity to become familiar with various tools recommended in the discussed patient population for measuring cognitive abilities.
Article Details
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Islas M, Ciampi E. Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. Biomedicine. 2019; 7: 22. https://doi.org/10.3390/biomedicines7010022.
2. Murray TJ. Multiple Sclerosis: The History of a Disease. Demos Medical Publishing 2005; 2: 461.
3. Langdon D. Cognitive impairment in multiple sclerosis – recent advances and future prospects. Eur Neurol Rev. 2010; 5(1): 69-72.
4. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci. 2006; 245(1): 169-75.
5. Sumowski J, Benedict R, Enzinger C et al. Cognition in multiple sclerosis. State of the field and priorities for the future. Neurology. 2018; 90: 278-88.
6. Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Mult Scler Relat Disord. 2018; 26: 183-91.
7. Figved N, Myhr K-M, Larsen J-P et al. Caregiver burden in multiple sclerosis. The impact of neuropsychiatric symptomps. J Neurol Neurosurg Psychiatry. 2007; 78: 1097-102.
8. Amato M, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006; 245(1-2): 41-6.
9. Chiaravalloti N, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008; 7: 1139-51.
10. DiGiuseppe G, Blair M, Morrow S. Prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis. Int J MS Care. 2018; 20: 153-7.
11. Johnen A, Landmeyer N, Bürkner P-C et al. Distinct cognitive impairments in different disease courses of multiple sclerosis. A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017, 83: 568-78.
12. Calabrese P. Neuropsychology of multiple sclerosis. An overview. J Neurol. 2006; 253(I): 10-5.
13. Ernst A. Autobiographical memory and future thinking impairments in multiple sclerosis: Cognitive and neural mechanisms, functional impact and rehabilitation. Ann Phys Rehabil Med. 2019 (w druku). https://doi.org/doi.org/10.1016/j.rehab.2019.06.006.
14. Dulau C, Deloire M, Diaz H et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol. 2017; 264(4): 740-8.
15. DiFilippo M, Portaccio E, Mancini A et al. Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nature Reviews. Neuroscience. 2019; 19: 599-609.
16. Benedict R, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol. 2007; 254(S2): II22-II25.
17. Portaccio E. Differential diagnosis, discerning depression from cognition. Acta Neurol Scand. 2016; 134(Suppl. 200): 14-8.
18. Roessler-Górecka M, Iwański S, Seniów J. Wartość pomiaru samoopisowego w diagnostyce neuropsychologicznej pacjentów z uszkodzeniem mózgu. Psychiatr Pol. 2013; 47(3): 465-74.
19. Langdon D, Amato M, Boringa B et al. Recommendation for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012; 18: 891-8.
20. Rao S. The Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for brief repeatable battery of the neuropsychological tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
21. Hansen S, Muenssinger J, Kronhofmann S et al. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery. BMC Neurol. 2015; 15: 246.
22. Benedict R, Fisher J, Archibald C et al. Minimal Neuropsychological Assessment of MS Patients: a consensus approach. Clin Neuropsychol. 2002; 16: 381-97.
23. Benedict R, Cookfair D, Gavett R et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4): 549-58.
24. Benedict R, Munschauer F, Linn R et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003; 9: 95.
25. Benedict R, Cox D, Thompson L et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 2004; 10(6): 675-8.
26. Fischer J, LaRocca N, Miller D et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999; 5(4): 251-9.
27. Strober L, Binder A, Nikelspuhr O et al. The Perceived Deficits Questionnaire. Perception, deficit or distress. Int. J. MS Care. 2016; 18(4): 183-90.
28. Parmenter B, Weinstock-Guttman B, Garg N. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler. 2007; 13(1): 52-7.
29. Benedict R, Duquin J, Jurgensen S et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler. 2008; 14: 940-6.
30. Meca-Lallana J, Prieto-Gonzalez J, Jimenez-Veiga J et al. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Mult Scler Relat Disord. 2019; 28: 50-6.
31. Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. 2018 (in press). https://doi.org/10.1016/j.rehab.2018.01.006.
2. Murray TJ. Multiple Sclerosis: The History of a Disease. Demos Medical Publishing 2005; 2: 461.
3. Langdon D. Cognitive impairment in multiple sclerosis – recent advances and future prospects. Eur Neurol Rev. 2010; 5(1): 69-72.
4. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci. 2006; 245(1): 169-75.
5. Sumowski J, Benedict R, Enzinger C et al. Cognition in multiple sclerosis. State of the field and priorities for the future. Neurology. 2018; 90: 278-88.
6. Clemens L, Langdon D. How does cognition relate to employment in multiple sclerosis? A systematic review. Mult Scler Relat Disord. 2018; 26: 183-91.
7. Figved N, Myhr K-M, Larsen J-P et al. Caregiver burden in multiple sclerosis. The impact of neuropsychiatric symptomps. J Neurol Neurosurg Psychiatry. 2007; 78: 1097-102.
8. Amato M, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006; 245(1-2): 41-6.
9. Chiaravalloti N, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008; 7: 1139-51.
10. DiGiuseppe G, Blair M, Morrow S. Prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis. Int J MS Care. 2018; 20: 153-7.
11. Johnen A, Landmeyer N, Bürkner P-C et al. Distinct cognitive impairments in different disease courses of multiple sclerosis. A systematic review and meta-analysis. Neurosci Biobehav Rev. 2017, 83: 568-78.
12. Calabrese P. Neuropsychology of multiple sclerosis. An overview. J Neurol. 2006; 253(I): 10-5.
13. Ernst A. Autobiographical memory and future thinking impairments in multiple sclerosis: Cognitive and neural mechanisms, functional impact and rehabilitation. Ann Phys Rehabil Med. 2019 (w druku). https://doi.org/doi.org/10.1016/j.rehab.2019.06.006.
14. Dulau C, Deloire M, Diaz H et al. Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis. J Neurol. 2017; 264(4): 740-8.
15. DiFilippo M, Portaccio E, Mancini A et al. Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nature Reviews. Neuroscience. 2019; 19: 599-609.
16. Benedict R, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol. 2007; 254(S2): II22-II25.
17. Portaccio E. Differential diagnosis, discerning depression from cognition. Acta Neurol Scand. 2016; 134(Suppl. 200): 14-8.
18. Roessler-Górecka M, Iwański S, Seniów J. Wartość pomiaru samoopisowego w diagnostyce neuropsychologicznej pacjentów z uszkodzeniem mózgu. Psychiatr Pol. 2013; 47(3): 465-74.
19. Langdon D, Amato M, Boringa B et al. Recommendation for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012; 18: 891-8.
20. Rao S. The Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for brief repeatable battery of the neuropsychological tests in multiple sclerosis. Milwaukee, WI: Medical College of Wisconsin, 1990.
21. Hansen S, Muenssinger J, Kronhofmann S et al. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery. BMC Neurol. 2015; 15: 246.
22. Benedict R, Fisher J, Archibald C et al. Minimal Neuropsychological Assessment of MS Patients: a consensus approach. Clin Neuropsychol. 2002; 16: 381-97.
23. Benedict R, Cookfair D, Gavett R et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4): 549-58.
24. Benedict R, Munschauer F, Linn R et al. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003; 9: 95.
25. Benedict R, Cox D, Thompson L et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler. 2004; 10(6): 675-8.
26. Fischer J, LaRocca N, Miller D et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999; 5(4): 251-9.
27. Strober L, Binder A, Nikelspuhr O et al. The Perceived Deficits Questionnaire. Perception, deficit or distress. Int. J. MS Care. 2016; 18(4): 183-90.
28. Parmenter B, Weinstock-Guttman B, Garg N. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler. 2007; 13(1): 52-7.
29. Benedict R, Duquin J, Jurgensen S et al. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler. 2008; 14: 940-6.
30. Meca-Lallana J, Prieto-Gonzalez J, Jimenez-Veiga J et al. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Mult Scler Relat Disord. 2019; 28: 50-6.
31. Ruet A, Brochet B. Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools. Ann Phys Rehabil Med. 2018 (in press). https://doi.org/10.1016/j.rehab.2018.01.006.